Hesperos Chief Scientist quoted in the Nature Medicine article discussing the state of the field, including rapid advancement with the adoption of the FDA Modernization Act 2.0.
New study published in Nature Scientific Reports validates the utility of Human-on-a-Chip to model Nonalcoholic Fatty Liver Disease (NAFLD)